Revenue: The sum of all revenue fields included for a company's operating activities.
Prelude Therapeutics Incorporated (PRLD) had Revenue of $7.00M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$7.00M |
$-127.17M |
|
-- |
|
$7.00M |
|
$146.71M |
|
$-139.71M |
|
$12.54M |
|
$-127.17M |
|
$-127.17M |
|
$-127.17M |
|
$-127.17M |
|
$-127.17M |
|
$-127.17M |
|
$-139.71M |
|
$-142.58M |
|
75.81M |
|
75.81M |
|
$-1.68 |
|
$-1.68 |
|
| Balance Sheet Financials | |
$135.90M |
|
$6.77M |
|
$39.62M |
|
$175.51M |
|
$25.64M |
|
-- |
|
$18.41M |
|
$44.06M |
|
$131.46M |
|
$131.46M |
|
$131.46M |
|
55.15M |
|
| Cash Flow Statement Financials | |
$-102.89M |
|
$90.19M |
|
$-0.12M |
|
$29.34M |
|
$16.52M |
|
$-12.82M |
|
$21.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.30 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
100.00% |
|
-1995.91% |
|
-1995.91% |
|
-2036.87% |
|
-1816.76% |
|
-1816.76% |
|
$-103.65M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-96.74% |
|
-96.74% |
|
-72.46% |
|
-96.74% |
|
$2.38 |
|
$-1.37 |
|
$-1.36 |
|